Morphosys Research Site

Madrid 28223

0 studies enrolling now · 6 studies all time

What they study most

Diffuse Large B Cell Lymphoma, Diffuse Large B-cell Lymphoma, Non-Hodgkin Lymphoma

Studies at this site

• Tafasitamab + Lenalidomide + R-CHOP Versus R-CHOP in Newly Diagnosed High-intermediate and High Risk DLBCL Patients — Running, not enrolling
• A Trial to Evaluate the Efficacy and Safety of Tafasitamab With Bendamustine (BEN) Versus Rituximab (RTX) With BEN in Adult Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL) — Completed
• Phase Ib Study to Assess Safety and Preliminary Efficacy of Tafasitamab or Tafasitamab Plus Lenalidomide in Addition to R-CHOP in Patients With Newly Diagnosed DLBCL — Completed
• Study of Fc-Optimized Anti-CD19 Antibody (MOR00208) to Treat Non-Hodgkin's Lymphoma (NHL) — Completed
• Lenalidomide Monotherapy in R/R DLBCL — Completed
• Observational Retrospective Cohort Study of Systemic Therapies for R/R DLBCL — Completed